Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
9974601 | The Journal of Heart and Lung Transplantation | 2005 | 5 Pages |
Abstract
First, to our knowledge, this study is the first to examine the incidence of allosensitization after Novacor implant in detail. In contrast with previous results of work with other VAD systems, as assessed by PRA levels, Novacor patients did not become sensitized. Second, compared with 220 non-BTT patients who received transplants during a similar time frame, Novacor BTT patients had equivalent rejection profiles and survival. Finally, the incidence of transplant-associated coronary artery disease was lower than in previous reports.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
David A. MD, Alan L. MD, Ira D. MD, Mark J. MD, Luis H. MD, Daniel J. MD, Thomas MD, Steven MD, Mary C. RN, Rhodora RN, Ming RN, David MD, Steven L. MD, PhD,